AU2001280982A1 - Compositions and methods for the therapy and diagnosis of colon cancer - Google Patents

Compositions and methods for the therapy and diagnosis of colon cancer

Info

Publication number
AU2001280982A1
AU2001280982A1 AU2001280982A AU8098201A AU2001280982A1 AU 2001280982 A1 AU2001280982 A1 AU 2001280982A1 AU 2001280982 A AU2001280982 A AU 2001280982A AU 8098201 A AU8098201 A AU 8098201A AU 2001280982 A1 AU2001280982 A1 AU 2001280982A1
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
compositions
methods
colon cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280982A
Inventor
Gordon E. King
Madeleine Joy Meagher
Heather Secrist
Jiangchun Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001280982A1 publication Critical patent/AU2001280982A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001280982A 2000-08-03 2001-07-31 Compositions and methods for the therapy and diagnosis of colon cancer Abandoned AU2001280982A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22328300P 2000-08-03 2000-08-03
US60/223,283 2000-08-03
US27976301P 2001-03-28 2001-03-28
US60/279,763 2001-03-28
US30205101P 2001-06-29 2001-06-29
US60/302,051 2001-06-29
PCT/US2001/024218 WO2002012328A2 (en) 2000-08-03 2001-07-31 Compositions and methods for the therapy and diagnosis of colon cancer

Publications (1)

Publication Number Publication Date
AU2001280982A1 true AU2001280982A1 (en) 2002-02-18

Family

ID=27397215

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280982A Abandoned AU2001280982A1 (en) 2000-08-03 2001-07-31 Compositions and methods for the therapy and diagnosis of colon cancer

Country Status (5)

Country Link
US (3) US20020136728A1 (en)
EP (1) EP1307556A2 (en)
AU (1) AU2001280982A1 (en)
CA (1) CA2417866A1 (en)
WO (1) WO2002012328A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
US7700359B2 (en) 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
JP2004512023A (en) * 2000-06-09 2004-04-22 コリクサ　コーポレイション Compositions and methods for treatment and diagnosis of colon cancer
DE10032608A1 (en) * 2000-07-07 2002-01-24 Magnus Von Knebel Doeberitz Ch Genes relevant for microsatellite-unstable (MSI +) tumors and their gene products
US20030166064A1 (en) * 2000-08-03 2003-09-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
EP2280030A3 (en) 2001-04-10 2011-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7504222B2 (en) * 2001-10-31 2009-03-17 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US7696320B2 (en) 2004-08-24 2010-04-13 Domantis Limited Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
GB0216727D0 (en) 2002-07-17 2002-08-28 Univ Cambridge Tech Genes
EP1579220B1 (en) 2002-12-20 2007-08-15 Roche Diagnostics GmbH Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
TWI340168B (en) * 2003-05-07 2011-04-11 Tosoh Corp Method of detecting micrometastasis
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US20090004193A1 (en) * 2004-07-23 2009-01-01 Bayer Healthcare Ag Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1)
EP2377950B1 (en) 2006-01-11 2014-09-17 Genomic Health, Inc. Gene expression markers for colorectal cancer prognosis
CA2662915A1 (en) * 2006-09-08 2008-03-13 Corixa Corporation Methods, compositions, and kits for the detection and monitoring of colon cancer
EP2425020A4 (en) 2009-05-01 2016-04-20 Genomic Health Inc Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy
US9458503B2 (en) 2009-07-02 2016-10-04 Nucleix Methods for distinguishing between natural and artificial DNA samples
JP5955771B2 (en) * 2009-10-22 2016-07-20 トーマス・ジェファーソン・ユニバーシティＴｈｏｍａｓ Ｊｅｆｆｅｒｓｏｎ Ｕｎｉｖｅｒｓｉｔｙ Cell-based anticancer composition and methods for making and using the same
US9752187B2 (en) 2009-12-11 2017-09-05 Nucleix Categorization of DNA samples
US9783850B2 (en) 2010-02-19 2017-10-10 Nucleix Identification of source of DNA samples
AU2016238253B2 (en) * 2015-03-25 2022-06-16 The General Hospital Corporation Digital analysis of circulating tumor cells in blood samples
US9476100B1 (en) 2015-07-06 2016-10-25 Nucleix Ltd. Methods for diagnosing bladder cancer
IL265451B (en) 2019-03-18 2020-01-30 Frumkin Dan Methods and systems for detecting methylation changes in dna samples

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053319A2 (en) * 1997-05-21 1998-11-26 The Johns Hopkins University Gene expression profiles in normal and cancer cells
EP1767636A3 (en) * 1998-12-23 2007-06-13 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use

Also Published As

Publication number Publication date
WO2002012328A8 (en) 2002-05-30
US20020136728A1 (en) 2002-09-26
US20050147615A1 (en) 2005-07-07
EP1307556A2 (en) 2003-05-07
CA2417866A1 (en) 2002-02-14
WO2002012328A2 (en) 2002-02-14
WO2002012328A3 (en) 2003-02-20
US20080317755A1 (en) 2008-12-25

Similar Documents

Publication Publication Date Title
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2003302892A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3483001A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer